Assertion: subunit vaccine | /r/CapableOf | target differentiation antigens
Facets:
Source sentences:
text: Two phase I studies have shown that nivolumab in combination with peptide vaccines targeting differentiation antigens is safe and produces an immunological response in melanoma patients (83, 84).